Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.7B | 3.2B | 3.0B | 2.8B |
Cost of revenue | 698.6M | 1.4B | 1.4B | 1.3B |
Gross profit | 2.0B | 1.8B | 1.7B | 1.5B |
Operating expense | ||||
Research & development | 193.4M | 205.0M | 195.1M | 232.1M |
Selling general and admin | 563.9M | 674.1M | 640.4M | 591.4M |
Other operating expenses | -40.2M | -5.9M | -2.2M | -7.8M |
Operating income | 1.2B | 835.4M | 762.0M | 565.4M |
Non operating interest income | ||||
Income | 245.5M | 149.5M | 303.3M | 305.3M |
Expense | — | — | — | — |
Other income expense | 42.8M | -360.4M | 140.3M | 21.0M |
Pretax income | 1.5B | 624.5M | 1.2B | 891.7M |
Tax provision | 211.8M | 49.9M | 83.6M | 51.2M |
Net income | 1.3B | 574.6M | 1.1B | 840.5M |
Basic EPS | 1.2 | 0.6 | 1 | 0.8 |
Diluted EPS | 1.2 | 0.6 | 1 | 0.8 |
Basic average shares | 1.0B | 1.0B | 1.0B | 1.0B |
Diluted average shares | 1.0B | 1.0B | 1.0B | 1.0B |
EBITDA | 1.2B | 2.1B | 747.6M | 544.9M |
Net income from continuing op. | — | — | — | — |
Minority interests | -10.4M | -16.2M | -14.9M | -17.4M |
Preferred stock dividends | — | — | — | — |